
---
title: '氢氧混合气改善COPD急性期症状'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202105/19/071209hem27m6tze02mtmz.png'
author: 科学网
comments: false
date: Wed, 19 May 2021 07:11:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202105/19/071209hem27m6tze02mtmz.png'
---

<div>   
<p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style="font-family: 宋体; line-height: 200%;">氢气医学虽然有<span style="font-family:Calibri">14</span>年的发现历史，人体试验研究论文也超过<span style="font-family:Calibri">100</span>篇，但过去并没有非常高质量的临床研究证据，所谓高质量一般是指多中心双盲安慰剂对照临床试验。一篇来自中国著名学者钟南山院士团队的研究论文正式发表，正式宣告氢气医学迈向高水平临床研究。</span><span style="font-family: Calibri; text-indent: 24px;"> </span><br></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style="font-family: Calibri; text-indent: 24px;"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202105/19/071209hem27m6tze02mtmz.png" title alt="图片1.png" referrerpolicy="no-referrer"><br></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">研究</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">目的</span><span style="font-family:Calibri">:</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"> </span><span style=";font-family:宋体;line-height:200%;font-size:16px">探讨氢氧混合</span><span style=";font-family:宋体;line-height:200%;font-size:16px">气</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">在改善慢性阻塞性肺疾病急性加重期</span><span style="font-family:Calibri">(AECOPD)</span><span style="font-family:宋体">患者症状方面是否优于氧。</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">就是和吸氧比较，氢氧混合吸入是否效果更好，由于对照为氧气吸入，其目的是确定氢气是否能发挥作用。</span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">研究</span><span style=";font-family:宋体;line-height:200%;font-size:16px">方法</span><span style=";font-family:宋体;line-height:200%;font-size:16px">：</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">这项前瞻性、随机、双盲、对照临床试验在</span><span style="font-family:Calibri">10</span><span style="font-family:宋体">个中心招募</span><span style="font-family:Calibri">AECOPD</span><span style="font-family:宋体">患者，并对呼吸困难、咳嗽和痰液评分</span><span style="font-family:Calibri">(BCSS)</span><span style="font-family:宋体">进行了至少</span><span style="font-family:Calibri">6</span><span style="font-family:宋体">分的评分。符合条件的</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">108</span><span style="font-family:宋体">名</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">患者被随机分配</span><span style="font-family:Calibri">(</span><span style="font-family:宋体">以</span><span style="font-family:Calibri">1:1</span><span style="font-family:宋体">的比例</span><span style="font-family:Calibri">)</span><span style="font-family:宋体">接受氢</span><span style="font-family:Calibri">/</span><span style="font-family:宋体">氧混合</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">气治疗</span><span style="font-family:Calibri">54</span><span style="font-family:宋体">名</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">或</span><span style=";font-family:宋体;line-height:200%;font-size:16px">吸</span><span style=";font-family:宋体;line-height:200%;font-size:16px">氧</span><span style=";font-family:宋体;line-height:200%;font-size:16px">治</span><span style=";font-family:宋体;line-height:200%;font-size:16px">疗</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">54</span><span style="font-family:宋体">名</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">。主要</span><span style=";font-family:宋体;line-height:200%;font-size:16px">研究</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">终点是第</span><span style="font-family:Calibri">7</span><span style="font-family:宋体">天</span><span style="font-family:Calibri">BCSS</span><span style="font-family:宋体">评分与基线相比的变化。</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">并</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">记录不良事件</span><span style="font-family:Calibri">(AEs)</span><span style="font-family:宋体">以评估安全性。</span></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">研究</span><span style=";font-family:宋体;line-height:200%;font-size:16px">结果</span><span style=";font-family:宋体;line-height:200%;font-size:16px">：</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">氢</span><span style="font-family:Calibri">/</span><span style="font-family:宋体">氧组呼吸困难、咳嗽和痰液</span><span style="font-family:Calibri">BCSS</span><span style="font-family:宋体">评分变化大于氧组</span><span style="font-family:Calibri">(</span><span style="font-family:宋体">−</span><span style="font-family:Calibri">5.3 vs.</span><span style="font-family:宋体">−</span><span style="font-family:Calibri">2.4;</span><span style="font-family:宋体">差异</span><span style="font-family:Calibri">:</span><span style="font-family:宋体">−</span><span style="font-family:Calibri">2.75 [95% CI</span><span style="font-family:宋体">−</span><span style="font-family:Calibri">3.27</span><span style="font-family:宋体">至−</span><span style="font-family:Calibri">2.22]</span><span style="font-family:宋体">，符合优势标准</span><span style="font-family:Calibri">)</span><span style="font-family:宋体">。</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">可以这样理解，用</span><span style=";font-family:宋体;line-height:200%;font-size:16px">呼吸困难、咳嗽和痰液</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">这</span><span style="font-family:Calibri">3</span><span style="font-family:宋体">种表现的综合评分进行比较，氢氧混合气吸入的效果比单纯吸氧效果好。结果提示，氢气对</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">慢性阻塞性肺疾病急性加重</span><span style=";font-family:宋体;line-height:200%;font-size:16px">有治疗作用。</span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">从第</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">天到第</span><span style="font-family:Calibri">6</span><span style="font-family:宋体">天的其他时间点观察到类似的结果。与对照组相比，氢</span><span style="font-family:Calibri">/</span><span style="font-family:宋体">氧组咳嗽评估测试得分显著降低</span><span style="font-family:Calibri">(</span><span style="font-family:宋体">−</span><span style="font-family:Calibri">11.00 vs.</span><span style="font-family:宋体">−</span><span style="font-family:Calibri">6.00,p</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri"><</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">0.001)</span><span style="font-family:宋体">。肺功能、动脉血气和无创氧饱和度的变化在组间及其他终点无显著差异。氢气</span><span style="font-family:Calibri">/</span><span style="font-family:宋体">氧气组</span><span style="font-family:Calibri">34</span><span style="font-family:宋体">例</span><span style="font-family:Calibri">(63.0%)</span><span style="font-family:宋体">患者和氧气组</span><span style="font-family:Calibri">42</span><span style="font-family:宋体">例</span><span style="font-family:Calibri">(77.8%)</span><span style="font-family:宋体">患者发生不良事件。在研究期间没有死亡和设备缺陷的报告。</span></span></p><p style="margin-left:0;text-indent:24px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"> <img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202105/19/071218oz005iezjs5kw1fe.png" title alt="图片2.png" referrerpolicy="no-referrer"></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">研究</span><span style=";font-family:宋体;line-height:200%;font-size:16px">结论</span><span style=";font-family:宋体;line-height:200%;font-size:16px">：</span><span style=";font-family:宋体;line-height:200%;font-size:16px">该</span><span style=";font-family:宋体;line-height:200%;font-size:16px">临床</span><span style=";font-family:宋体;line-height:200%;font-size:16px">试验</span><span style=";font-family:宋体;line-height:200%;font-size:16px">结果</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">表明，氢氧疗法优于氧疗法对</span><span style="font-family:Calibri">AECOPD</span><span style="font-family:宋体">患者具有可接受的安全性和耐受性。</span></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">2020</span><span style="font-family:宋体">年</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">月</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">日 中国国家食药监批准氢氧雾化吸入为三类医疗器械，其治疗疾病的适应症就是</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">慢性阻塞性肺疾病急性加重期</span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px">这一项研究应该就是批准该适应症的重要证据。不过，从研究结果看，氢氧混合气对</span><span style=";font-family:宋体;line-height:200%;font-size:16px">肺功能、动脉血气和无创氧饱和度</span><span style=";font-family:宋体;line-height:200%;font-size:16px">并没有发现比吸氧更好，这说明氢气虽然有一定作用，但对</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">COPD</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">这种慢性病来说，很难在短时间（</span><span style="font-family:Calibri">7</span><span style="font-family:宋体">天）发挥决定性作用，要实现更理想的作用，可能需要长期吸入氢气，当然这仍然需要用</span><span style="font-family:Calibri">RCT</span><span style="font-family:宋体">研究才能最后确定。这一研究论文的通讯作者为广州医科大学钟南山院士，感谢钟院士为氢气医学做出的重要贡献，为天下人能早日使用安全有效的氢气疗法奠定了重要基础。</span></span></p><p style="margin-left:0;text-indent:24px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"> <img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202105/19/071233ww8gvziqhh3hzihh.png" title alt="图片3.png" referrerpolicy="no-referrer"></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">全分析集（</span><span style="font-family:Calibri">FAS</span><span style="font-family:宋体">）指合格病例和脱落病例的集合，但不包括剔除病例。主要疗效指标缺失时，根据意向性分析，用前一次结果结转。符合方案集（</span><span style="font-family:Calibri">PPS</span><span style="font-family:宋体">）指符合纳入标准、不符合排除标准、完成治疗方案的病例集合，即对符合试验方案、依从性好、完成</span><span style="font-family:Calibri">CRF</span><span style="font-family:宋体">规定填写内容的病例进行分析（</span><span style="font-family:Calibri">PP</span><span style="font-family:宋体">分析）。其是</span><span style="font-family:Calibri">FAS </span><span style="font-family:宋体">的一个子集，在这个数据集中每位受试者是依从性好，不违背方案，主要指标的基线值完备；未使用违背方案的药物。</span></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">随时了解氢气医学进展欢迎加入氢思语粉丝群</span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:16px"> </span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202105/19/163153wt3ie35mqn1qzvtm.jpg" title alt="微信图片_20210413104508.jpg" width="169" height="253" style="width: 169px; height: 253px;" referrerpolicy="no-referrer"><br></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:16px"> </span></p><p style="line-height: 16px;"><img style="vertical-align: middle; margin-right: 2px;" src="https://cors.zfour.workers.dev/?http://blog.sciencenet.cn/static/ueditor/dialogs/attachment/fileTypeImages/icon_txt.gif" referrerpolicy="no-referrer"><a style="font-size:12px; color:#0066cc;" href="http://bbs.sciencenet.cn/home.php?mod=attachment&filename=%D6%D3%C4%CF%C9%BD%D4%BA%CA%BF%20%C7%E2%C6%F8%B6%D4COPD%BC%B1%D0%D4%B7%A2%D7%F7%B5%C4%D6%CE%C1%C62021.pdf&id=723422" title="钟南山院士 氢气对COPD急性发作的治疗2021.pdf">钟南山院士 氢气对COPD急性发作的治疗2021.pdf</a></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:16px"></span><br></p><p><br></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自孙学军科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-41174-1287198.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-41174-1287198.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-41174-1284949.html" target="_black">牛皮癣研究进行时！</a><br>                    <!--大赛结束-->
                                        
  
</div>
            